Lisa Dean Moseley Fellowship in Cancer Stem Cell Research

The Cawley Center for Translational Cancer Research (CTCR) at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute is seeking applicants for the Lisa Dean Moseley Post-doctoral fellowship in Translational Cancer Stem Cell Research.

This program offers training and mentorship to post-doctoral fellows and early career physician scientists in a unique environment encompassing both translational and clinical oncology research.

The awardees will be hosted within established research labs in the Cawley CTCR and will be embedded into multi-disciplinary teams comprised of scientists, clinicians and patient advocates. Fellows will be offered a one-year stipend plus benefits with an optional second year dependent upon performance. Applicants should be within one year of completion of a Ph.D. in biological sciences, immunology, cancer research or a related field, or a post-graduate resident within 1-3 years of completion of a medical degree.

Applicants should send the following to CTCR@Christianacare.org: Cover letter, Curriculum Vitae, including full publication list, names and contact information (email and phone number) of 2-3 references (including Ph.D. or residency supervisor).

The Lisa Dean Moseley Fellowship in Cancer Stem Cell Research is made possible through funding generously provided by the Lisa Dean Moseley Foundation based in Wilmington, Delaware.

The Helen F. Graham Cancer Center & Research Institute, a National Cancer Institute Community Oncology Research Program, is part of ChristianaCare, one of the country’s largest health care systems with 52,339 admissions, 37,634 surgeries, and 195,998 emergency department visits. With more than 248,000 patient visits, the Graham Cancer Center is recognized as a national model for multidisciplinary cancer care and a top enroller in U.S. clinical research trials (29% accrual rate). Annually there are more than 3,200 newly diagnosed cancer patients. Its Cawley Center for Translational Cancer Research, located in the Graham Cancer Center, consists of a Tissue Procurement Center, world-renowned Gene Editing Institute, Statewide High-Risk Family Cancer Registry with eight full-time genetic counselors, and collaborations with acclaimed scientists at The Wistar Cancer Institute in Philadelphia. The Cawley CTCR is opening new avenues to more quickly translate cancer science into cancer medicine. The 240,000 square foot outpatient cancer center has 12 multidisciplinary disease site centers allowing patients to see the three disciplines of surgical, medical and radiation oncology, including subspecialists and support service teams, in one visit.